期刊文献+

Duchenne型进行性肌营养不良40例临床分析 被引量:7

Clinical analysis of 40 children with Duchenne muscular dystrophy
下载PDF
导出
摘要 目的探讨Duchenne型进行性肌营养不良(DMD)的临床特点及肌酶、肌电图、肌肉活检的诊断价值。方法对40例经dystrophin蛋白检测确诊的DMD患儿的临床特征及实验室检查资料进行分析。结果40例患儿平均年龄7.2岁,平均发病年龄4.5岁,15%患儿有家族史。40例患儿均有典型的临床症状和体征,肌酶升高以肌酸磷酸激酶(CPK)升高为主,≤8岁年龄组CPK值高于>8岁组。所有患儿肌肉活检均有肌纤维变性和坏死,12.5%的患儿尚伴炎性细胞浸润。在有肌源性损害同时,15%的患儿肌电图尚有神经源性损害。结论血清肌酶、肌电图及肌活检是DMD重要的辅助诊断指标,对于肌电图有神经源性损害和肌活检病理检查有炎性细胞浸润者,应进行基因检测和(或)dystrophin蛋白检测。 Objectives To explore the clinical characteristics of the children with Duchenne muscular dystrophy and the diagnostic value of creatase, electromyogram and muscle biopsy. Methods The clinical and laboratory data was analyzed in 40 children with confirmed diagnosis of Duchenne muscular dystrophy by dystrophin detection. Results Mean age of the 40 children was 7.2 years old, and their mean onset age was 4.5 years old, and 15% of them had positive family history. All presented typical signs and symptoms of the disease. Level of creatine phosphokinase in patients of eight years old or less was higher than that of those older than eight. All muscular biopsy showed muscular degeneration and necrosis, with 12.5% accompanied with inflammatory cell infiltration. Electromyogram showed muscle damage in all and 15% of them also showed neuropathy. Conclusions Creatase, electromyogram and muscle biopsy are important supplementary diagnostic methods. For patients with neuropathy in electromyogram and inflammatory cell infiltrate in biopsy, determination of gene and dystrophin should be performed.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2008年第2期96-98,共3页 Journal of Clinical Pediatrics
关键词 DUCHENNE型肌营养不良 肌酶 肌电图 肌肉活检 Duchenne muscular dystrophy creatase electromyogram muscle biopsy
  • 相关文献

参考文献13

  • 1黄根池 李卫东 等.肌电图表现为神经原性损害的进行性肌营养不良10例报告[J].脑与神经疾病杂志,1999,7(3):147-147.
  • 2丁新生.进行性肌营养不良症[M]//.王维治,罗祖明,丁新生.神经病学.4版.北京:人民军医出版社,2000.291-294.
  • 3王锁彬,沈定国.Dystrophin相关蛋白与肌营养不良[J].中华神经科杂志,2000,33(6):371-373. 被引量:7
  • 4肖静,邹丽萍,吴沪生,方方,丁昌红,金洪.磷酸肌酸治疗Dystrophin缺失型肌营养不良临床研究[J].临床儿科杂志,2005,23(5):278-279. 被引量:3
  • 5夏经,郭亚芳.小儿神经肌肉疾病的治疗进展[J].临床儿科杂志,2005,23(5):265-270. 被引量:5
  • 6Deconinck N, Dan B. Pathophysiology of Duchenne muscular dystrophy : current hypotheses [J ]. Pediatr Neurol, 2007,36 (1) : 1-7.
  • 7Bonilla E, Samitt CE, Miranda AF, et al. Duchenne muscular dystrophy:deficiency of dystrophin at the muscle cell surface [J]. Cell, 1988,54(4) :447-452.
  • 8Wong LJ, Wladyka C, Mardach-Verdon R. A mitochondrial DNA mutation in a patient with an extensive family history of Duchenne muscular dystrophy [J]. Muscle Nerve,2004,30( 1 ) : 118-122.
  • 9Takagi Y, Yasuhara T, Gomi K. Creatine kinase and its isozymes [J]. Rinsho Byori,2001,Suppl 116:52-61 [Japanese].
  • 10Mondelli M, Rossi A, Malandrini A, et al. Axonal motor and sensory neuropathy in myotonic dystrophy [J]. Acta Neurol Stand, 1993,88(2) : 141-148.

二级参考文献35

  • 1柳太云,张成.假肥大型肌营养不良症基因治疗新进展[J].国外医学(神经病学.神经外科学分册),2004,31(3):293-296. 被引量:2
  • 2Byrne E, Kornberg AJ, Kapsa R, et al.Duchenne musculare dystrophy: hopes for the sesquicentenary.Med J Aust, 2003, 179(9): 463-464.
  • 3Wagner KR, Hamed S, Hadley DW, et al.Gentamycin treatment of Duchenne muscular dystrophy due to nonsence mutation.Ann Neurol, 2001, 49(6): 706-711.
  • 4Moser H.Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.Hum Genet, 1984, 66(1): 17-40.
  • 5Alman BA, Raza SN, Biggar WD.Steroid treatment and the development of scoliosis in males with Duchenne muscular dystrophy.J Bone Joint Surg Am, 2004, 86-A(3): 519-524.
  • 6Connolly AM, Schierbecker J, Renna R, et al.High dose weekly oral prednisone improves strength in boys with Duchenne muscular dystrophy.Neuromuscul Disord, 2002, 12(10): 917-925.
  • 7Tidball JG, Wehling-Henricks M.Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events.Pediatr Res, 2004, 56(6): 831-884.
  • 8Fenichel GM, Griggs RC, Kissel J, et al.A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne muscular dystrophy.Neurology, 2001, 56(8): 1075-1079.
  • 9Fowler EG, Greves MC, Wetzel GT, et al.Pilot trial of albuterol in Duchenne and Becker muscular dystrophy.Neurology, 2004, 62(6): 1006-1008.
  • 10Kinali M, Mercuri E, Main M, et al.Pilot study of albuterol in spinal muscular atrophy.Neurology, 2002, 59(4): 609-610.

共引文献13

同被引文献79

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部